Comparison of Captisol-Enabled ™ Iohexol and Omnipaque™ in Patients With Impaired Renal Function Undergoing Coronary Angiography

Condition:   Contrast-induced Nephropathy Interventions:   Drug: CE-Iohexol;   Drug: Iohexol Sponsor:   Ligand Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials